The head of the department is hematologist of the highest category, Candidate of Medical Sciences, Lilia G. Gorenkova.
The department was established at the NMRC for Hematology in August 2022 The main mission of the department is the development and implementation of modern chemotherapy protocols as well as immune and targeted therapy in adult patients with acute leukemia and malignant lymphomas. The department carries out a full range of diagnostic measures necessary to verify the diagnosis of acute leukemia and lymphoma. The main scientific direction of the department is the development of modern methods of diagnosis and therapy of acute lymphoblastic leukemia in adults in order to improve long-term results.
The department has 15 beds. There are 2 single-room and 5 multi-bed wards (2,3 and 4-bed).